Fresh analysis reveals that people who stop using blockbuster GLP-1 drugs like Wegovy and Mounjaro may regain lost weight far faster than those who end traditional diet and exercise programs.
Published data in a leading health publication points out that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"People buying these medications should be cognizant of the potential of rapid weight regain when the treatment ends," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a reversion to pre-treatment weight within about one and a half years.
Weighing Therapies
The analysis, which reviewed 37 of studies involving over 9,000 of patients, contrasted the effects of these new drugs with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise typically have a more gradual weight regain—around 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Experts believe the way of the injections accounts for the amplified weight return.
These medications copy a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 levels several times higher than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating much more probable."
An Ongoing Disease?
Medical guidelines suggest the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of relapse, the treatment might need to be ongoing.
This opinion is reinforced by drug manufacturers, who say that the findings "underscore the chronic character of excess weight," similar to managing conditions like high blood pressure.
User Accounts
People who have discontinued the jabs explain a sudden resurgence of appetite.
"I experienced something activating and I was suddenly extremely hungry," said one woman.
The struggle is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Significant Interest
Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire remaining high.
- Adoption is higher among women than men.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are effective agents for weight loss, they are not a permanent solution and maintained weight loss relies on integrated lifestyle changes.
